Nexavir, the “next generation Kutapressin,” is an amino acid complex that New York-based CFS/FM specialist Derek Enlander, MD, uses in conjunction with his nutritional protocol for managing ME/CFS. Dr. Enlander discusses Kutapressin’s 60-year history, and the Nexavir producer’s efforts to make the treatment more affordable and accessible – through development of different delivery modes (patch, topicals & soon, capsules) and streamlined production. Currently Nexavir is administered by intermuscular injection.
How does it work? Dr. Enlander says his current best guess regarding how this drug, with a long history of safety, helps patients is that the amino acid complex in Nexavir may act to improve function of a defective methylation cycle in ME/CFS. It is thought to have anti-inflammatory and anti-viral properties. See also "Nexavir (Kutapressin) for ME/CFS" at ESME-eu.com.